Form 8-K - Current report:
SEC Accession No. 0000950142-25-001434
Filing Date
2025-05-20
Accepted
2025-05-20 14:24:32
Documents
13
Period of Report
2025-05-19
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K eh250630168_8k.htm   iXBRL 8-K 25122
2 EXHIBIT 99.1 eh250630168_ex9901.htm EX-99.1 21091
  Complete submission text file 0000950142-25-001434.txt   218371

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE wrby-20250519.xsd EX-101.SCH 3023
4 XBRL LABEL FILE wrby-20250519_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE wrby-20250519_pre.xml EX-101.PRE 22364
15 EXTRACTED XBRL INSTANCE DOCUMENT eh250630168_8k_htm.xml XML 3678
Mailing Address 233 SPRING STREET 6TH FLOOR EAST NEW YORK NY 10013
Business Address 233 SPRING STREET 6TH FLOOR EAST NEW YORK NY 10013 (646) 847-7215
Warby Parker Inc. (Filer) CIK: 0001504776 (see all company filings)

EIN.: 800423634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40825 | Film No.: 25967926
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)